These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21904790)

  • 1. Neural stem cell transplantation as a therapeutic approach for treating lysosomal storage diseases.
    Shihabuddin LS; Cheng SH
    Neurotherapeutics; 2011 Oct; 8(4):659-67. PubMed ID: 21904790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engraftment of enteric neural progenitor cells into the injured adult brain.
    Belkind-Gerson J; Hotta R; Whalen M; Nayyar N; Nagy N; Cheng L; Zuckerman A; Goldstein AM; Dietrich J
    BMC Neurosci; 2016 Jan; 17():5. PubMed ID: 26810757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
    Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
    J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lysosomal storage disorders: cell therapy and gene therapy.
    Eto Y; Shen JS; Meng XL; Ohashi T
    J Inherit Metab Dis; 2004; 27(3):411-5. PubMed ID: 15190197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y
    J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Stem Cell Transplantation and CNS Diseases.
    Gonzalez R; Hamblin MH; Lee JP
    CNS Neurol Disord Drug Targets; 2016; 15(8):881-886. PubMed ID: 27577573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
    Critchley BJ; Gaspar HB; Benedetti S
    Mol Ther; 2023 Mar; 31(3):657-675. PubMed ID: 36457248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploitation of genetically modified neural stem cells for neurological disease.
    Ho AL; Keshavarzi S; Levy ML
    Adv Exp Med Biol; 2010; 671():74-92. PubMed ID: 20455497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell gene therapy for Niemann-Pick disease and other lysosomal storage diseases.
    Schuchman EH
    Chem Phys Lipids; 1999 Nov; 102(1-2):179-88. PubMed ID: 11001572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
    De Filippis L; Zalfa C; Ferrari D
    CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
    Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
    Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status of hematopoietic stem cell transplantation in lysosomal storage disease.
    Malatack JJ; Consolini DM; Bayever E
    Pediatr Neurol; 2003 Nov; 29(5):391-403. PubMed ID: 14684234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS-directed gene therapy for lysosomal storage diseases.
    Sands MS; Haskins ME
    Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural stem cell-mediated therapy for rare brain diseases: perspectives in the near future for LSDs and MNDs.
    de Filippis L
    Histol Histopathol; 2011 Aug; 26(8):1093-109. PubMed ID: 21692041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection.
    De Feo D; Merlini A; Laterza C; Martino G
    Curr Opin Neurol; 2012 Jun; 25(3):322-33. PubMed ID: 22547103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem/progenitor cell transplantation for spinal cord injury treatment; A systematic review and meta-analysis.
    Yousefifard M; Rahimi-Movaghar V; Nasirinezhad F; Baikpour M; Safari S; Saadat S; Moghadas Jafari A; Asady H; Razavi Tousi SM; Hosseini M
    Neuroscience; 2016 May; 322():377-97. PubMed ID: 26917272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell replacement therapy in neurological disease.
    Goldman SA; Windrem MS
    Philos Trans R Soc Lond B Biol Sci; 2006 Sep; 361(1473):1463-75. PubMed ID: 16939969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases.
    Siddiqi F; Wolfe JH
    Hum Gene Ther; 2016 Oct; 27(10):749-757. PubMed ID: 27420186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for lysosomal storage disorders.
    Gritti A
    Expert Opin Biol Ther; 2011 Sep; 11(9):1153-67. PubMed ID: 21548845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.